• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在激素缺乏的培养基中,培养的人前列腺癌细胞向神经内分泌细胞表型的转分化。

Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium.

作者信息

Shen R, Dorai T, Szaboles M, Katz A E, Olsson C A, Buttyan R

机构信息

Molecular Urology Laboratory of the Department of Urology, and the Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

出版信息

Urol Oncol. 1997 Mar-Apr;3(2):67-75. doi: 10.1016/s1078-1439(97)00039-2.

DOI:10.1016/s1078-1439(97)00039-2
PMID:21227062
Abstract

Neuroendocrine (NE) cells are enigmatically found in association with human prostate cancers and their numbers are reported to increase in advanced and hormoneresistant tumors. The origin of this cell type and the reason for their appearance in prostate tumors remains unresolved. Previously, Bang et al. (Proc Natl Acad Sci USA 1994;91:5330) reported that dibutyryl adenosine 3',5'-cyclic phosphate (db-cAMP), an agent that upregulates intracellular cAMP, was able to induce a NE cell-like phenotype of cultured human prostate cancer cells, including the androgen-sensitive LNCaP line. Here we report that chronic incubation of LNCaP cells in a medium containing 10% charcoal-stripped fetal bovine serum (CSFBS) likewise induces NE differentiation of these cells. Within 5 days of switching low density cultures of LNCaP cells to this modified medium, the cells growth arrest and acquire an altered morphology with numerous cytoplasmic secretory granules and elongated processes that resemble cultured neurons. This morphology predominates at 10 days with complete transformation seen by 20 days of culture. Electron microscopic analysis of sections of CS-FBS maintained cells showed the presence of abundant dense core secretory granules characteristic of NE cells. Immunohistochemical staining identified the upregulation of the expression of NE markers bombesin, neuron-specific enolase, and S-100 in this modified culture medium. Once established, the NE cell-like phenotype was found to be reversible upon replacement with a medium containing unmodified fetal bovine serum, but not by direct supplementation of CS-FBS medium with dihydrotestosterone (DHT) (I nM). DHT supplementation did, however, suppress the development of the NE cell-like phenotype when it was present at the initiation of exposure to CS-FBS medium. In contrast to db-cAMP treatment, which did not affect prostate specific antigen (PSA) or androgen receptor (AR) expression of LNCaP cells, NE-differentiated LNCaP cells derived in this hormone-deficient medium showed marked downregulation of PSA and AR expression. These in vitro results further support the concept that prostate cancer cells can tranform in vivo to cells with a NE phenotype and suggest that this transformation might be accelerated in patients by certain therapies for prostate cancer.

摘要

神经内分泌(NE)细胞神秘地与人类前列腺癌相关联,据报道其数量在晚期和激素抵抗性肿瘤中会增加。这种细胞类型的起源及其在前列腺肿瘤中出现的原因仍未明确。此前,Bang等人(《美国国家科学院院刊》1994年;91:5330)报道,二丁酰腺苷3',5'-环磷酸酯(db-cAMP),一种上调细胞内cAMP的物质,能够诱导培养的人类前列腺癌细胞呈现NE细胞样表型,包括雄激素敏感的LNCaP细胞系。在此我们报道,将LNCaP细胞在含有10%活性炭处理胎牛血清(CSFBS)的培养基中长时间培养同样能诱导这些细胞发生NE分化。将低密度培养的LNCaP细胞转入这种改良培养基5天内,细胞生长停滞并获得改变的形态,具有大量细胞质分泌颗粒和类似培养神经元的细长突起。这种形态在10天时占主导,培养20天时可见完全转变。对CS-FBS培养的细胞切片进行电子显微镜分析显示存在大量典型的NE细胞致密核心分泌颗粒。免疫组织化学染色鉴定出在这种改良培养基中NE标志物蛙皮素、神经元特异性烯醇化酶和S-100的表达上调。一旦形成,发现NE细胞样表型在用含有未处理胎牛血清的培养基替换后是可逆的,但用二氢睾酮(DHT)(1 nM)直接补充CS-FBS培养基则不能使其逆转。然而,在开始接触CS-FBS培养基时存在DHT可抑制NE细胞样表型的发展。与不影响LNCaP细胞前列腺特异性抗原(PSA)或雄激素受体(AR)表达的db-cAMP处理不同,在这种激素缺乏培养基中诱导产生的NE分化LNCaP细胞显示PSA和AR表达明显下调。这些体外结果进一步支持了前列腺癌细胞可在体内转变为具有NE表型细胞的概念,并表明这种转变在前列腺癌患者中可能会因某些前列腺癌治疗而加速。

相似文献

1
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium.在激素缺乏的培养基中,培养的人前列腺癌细胞向神经内分泌细胞表型的转分化。
Urol Oncol. 1997 Mar-Apr;3(2):67-75. doi: 10.1016/s1078-1439(97)00039-2.
2
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.前列腺肿瘤细胞获得神经内分泌特征是可逆的:对前列腺癌进展的影响。
Cancer Res. 1999 Aug 1;59(15):3821-30.
3
Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.人前列腺癌细胞向神经内分泌样表型转分化的多途径
Biochim Biophys Acta. 2001 May 28;1539(1-2):28-43. doi: 10.1016/s0167-4889(01)00087-8.
4
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.前列腺癌细胞在体外和体内向神经内分泌细胞表型的转分化。
J Urol. 1999 Nov;162(5):1800-5.
5
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.雄激素剥夺诱导雄激素敏感的LNCaP细胞发生人前列腺上皮神经内分泌分化。
Endocr Relat Cancer. 2006 Mar;13(1):151-67. doi: 10.1677/erc.1.01043.
6
Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.受体蛋白酪氨酸磷酸酶α信号传导参与雄激素耗竭诱导的雄激素敏感型LNCaP人前列腺癌细胞的神经内分泌分化。
Oncogene. 2003 Oct 2;22(43):6704-16. doi: 10.1038/sj.onc.1206764.
7
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.雄激素受体抑制前列腺癌细胞中的神经内分泌转分化过程。
Mol Endocrinol. 2003 Sep;17(9):1726-37. doi: 10.1210/me.2003-0031. Epub 2003 May 29.
8
1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.1α,25-二羟基维生素D3在LNCaP人前列腺癌细胞中的作用是雄激素依赖性的。
Endocrinology. 1997 Aug;138(8):3290-8. doi: 10.1210/endo.138.8.5328.
9
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.NE-10神经内分泌癌促进去势小鼠体内LNCaP异种移植瘤的生长。
Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117.
10
Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.前列腺癌中的神经内分泌分化:聚焦于其病理生理机制和病理特征。
G Chir. 2010 Nov-Dec;31(11-12):568-74.

引用本文的文献

1
Cell Models of Castration Resistant and High Dose Testosterone-Resistant Prostate Cancer Recapitulate the Heterogeneity of Response Observed in Clinical Practice.去势抵抗性和高剂量睾酮抵抗性前列腺癌的细胞模型概括了临床实践中观察到的反应异质性。
Cancers (Basel). 2025 Feb 10;17(4):593. doi: 10.3390/cancers17040593.
2
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer.前列腺癌中神经内分泌转分化驱动因子的治疗性利用
Cells. 2024 Dec 3;13(23):1999. doi: 10.3390/cells13231999.
3
Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer.
与前列腺癌进展相关的分子生物标志物的调控
Int J Mol Sci. 2024 Apr 10;25(8):4171. doi: 10.3390/ijms25084171.
4
Prostate transmembrane androgen inducible protein 1 : regulation and clinical implications.前列腺跨膜雄激素诱导蛋白1:调控及临床意义
Front Oncol. 2023 Dec 20;13:1298660. doi: 10.3389/fonc.2023.1298660. eCollection 2023.
5
Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN/STAT3).阴阳 1 通过非经典 WNT 通路(FYN/STAT3)促进前列腺癌细胞的神经内分泌分化。
Clin Transl Med. 2023 Oct;13(10):e1422. doi: 10.1002/ctm2.1422.
6
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies.PDE4D7 表达缺失促进雄激素非依赖性、神经内分泌分化和 DNA 修复改变:对治疗策略的影响。
Br J Cancer. 2023 Oct;129(9):1462-1476. doi: 10.1038/s41416-023-02417-5. Epub 2023 Sep 22.
7
Establishment of the LNCaP Cell Line - The Dawn of an Era for Prostate Cancer Research.LNCaP细胞系的建立——前列腺癌研究新时代的曙光。
Cancer Res. 2022 May 3;82(9):1689-1691. doi: 10.1158/0008-5472.CAN-22-1065.
8
ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.ETS 转录因子 ELF3(ESE-1)是良性和恶性前列腺中的细胞周期调节剂。
FEBS Open Bio. 2022 Jul;12(7):1365-1387. doi: 10.1002/2211-5463.13417. Epub 2022 May 6.
9
Role of MicroRNAs in Neuroendocrine Prostate Cancer.微小RNA在神经内分泌前列腺癌中的作用
Noncoding RNA. 2022 Mar 30;8(2):25. doi: 10.3390/ncrna8020025.
10
Narrative review of challenges in the management of advanced neuroendocrine prostate cancer.晚期神经内分泌前列腺癌管理挑战的叙述性综述
Transl Androl Urol. 2021 Oct;10(10):3953-3962. doi: 10.21037/tau-20-1131.